ClinicalTrials.Veeva

Menu

Metabolic Syndrome and Inflammatory Markers

F

Free Islamic University of Medical Sciences

Status

Completed

Conditions

Metabolic Syndrome

Treatments

Behavioral: Ramadan Fasting

Study type

Interventional

Funder types

Other

Identifiers

NCT00433082
1345104

Details and patient eligibility

About

The metabolic syndrome has been recognized as a proinflammatory state. It has been shown that many different diets such as Mediterranean diet, DASH diet, Foods with low glycemic index and low saturated fat diet, independent of weight loss, may be effective in improving the metabolic syndrome. Our objective was to evaluate the effect of Ramadan fasting on High-sensitive C-reactive protein (hs-CRP) and fibrinogen levels in metabolic syndrome.

Sex

Male

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Males with metabolic syndrome

Exclusion criteria

  • Conditions with insulin resistance including;
  • Type 2 diabetes mellitus,
  • Infections,
  • Stresses,
  • Uremia,
  • Acromegaly,
  • Glucocorticoid excess,
  • Hypertension ,
  • Cirrhosis and
  • Any addiction or drug therapy and conditions witch cause changes in hs-CRP and fibrinogen levels including infection, trauma, infarction, inflammatory arthritis, various neoplasm and liver diseases.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems